Little is known about the role of subcellular trafficking of estrogen receptor (ER) subtypes in the acute estrogen (E 2 )-mediated alleviation of oxidative stress. We tested the hypothesis that ERα migration to the cardiac myocyte membrane mediates the acute E 2 -dependent improvement of cellular redox status. Main methods: Myocardial distribution of subcellular ERα, ERβ and G-protein coupled estrogen receptor (GPER) was determined in proestrus sham-operated (SO) and in ovariectomized (OVX) rats, acutely treated with E 2 (1 μg/kg) or a selective ERα (PPT), ERβ (DPN) or GPER (G1) agonist (10 μg/kg), by immunofluorescence and Western blot. We measured ROS and malondialdehyde (MDA) levels, and catalase and superoxide dismutase (SOD) activities to evaluate myocardial antioxidant/redox status. Key findings: Compared with SO, OVX rats exhibited higher myocardial ROS and MDA levels, reduced catalase and SOD activities, along with diminished ERα, and enhanced ERβ and GPER, localization at cardiomyocyte membrane. Acute E 2 or an ERα (PPT), but not ERβ (DPN) or GPER (G1), agonist reversed these responses in OVX rats and resulted in higher ERα/ERβ and ERα/GPER ratios at the cardiomyocytes membrane. PPT or DPN enhanced myocardial Akt phosphorylation. We present the first evidence that preferential aggregation of ERα at the cardiomyocytes plasma membrane is ERα-dependent, and underlies E 2 -mediated reduction in oxidative stress, at least partly, via the enhancements of myocardial catalase and SOD activities in OVX rats. Significance: The findings highlight ERα agonists as potential therapeutics for restoring the myocardial redox status following E 2 depletion in postmenopausal women.
Introduction
The favorable cardiovascular effects of estrogen (E 2 ) were questioned by findings of the first Women's Health Initiative (WHI) study [1] . However, recent reappraisal of the WHI study showed that E 2 alone replacement therapy conferred cardioprotection in women aged 50-59 years [2] . The estrogen receptor (ER) subtype(s) mediation of E 2 's cardiac effects [3] [4] [5] may involve many factors including: the subcellular location of the ERs, the interactions between the ER subtypes, and the timing of the response [6] . Currently, little is known about the role of ER subtypes and their subcellular trafficking in myocardial oxidative stress and its alleviation by E 2 replacement in menopausal women or in experimental models. Therefore, addressing these clinically relevant issues will advance our understanding of the protective cardiovascular effects of E 2 replacement.
Temporal and spatial aspects contribute to the complex nature of E 2 effects [7, 8] . E 2 binds to ERs, which continuously shuttle between various subcellular compartments, to produce their biological effects [9, 10] . There are three ER subtypes, which include the classical ERα and ERβ and the seven transmembrane-domain G-protein-coupled estrogen receptor (GPER). The latter also shuttles between the nucleus and the plasma membrane in response to E 2 [11, 12] . Activation of the docked ER at the plasma membrane [13] [14] [15] triggers signaling cascades that mediate the biological effects of E 2 , such as activation of PI3K/Akt signaling [16] and regulation of vascular tone [17] .
All three ER subtypes are expressed in the myocardium [18, 19] , and are associated with the myocyte membrane [20] via caveolin-3 (Cav3) [21] , a major component of lipid microdomains [22] . ERs interact with caveolins throughout the cardiovascular system [15, 23, 24] , and acute E 2 enhances Cav3-ERα association on isolated rat cardiomyocytes cell surface [24] . However, there is little information on ERβ and GPER trafficking in cardiac myocytes following their acute activation with nonselective (E 2 ) or highly selective agonist for ERα (PPT) [25] , ERβ (DPN) [26] or GPER (G1) [27] . Equally important, the functional relevance of such trafficking remains unknown. Functional crosstalk between the ER subtypes exists in various cell types including cancer [28, 29] and uterine epithelial [30] cells, but similar studies are lacking in cardiac myocytes. Interestingly, acute E 2 restores myocardial catalase activity of OVX rats to proestrus SO rats levels [31] . However, the implicated ER subtype in this latter effect remains unknown.
In the present study, we tested the hypothesis that E 2 -mediated activation of ERα at the cardiomyocyte plasma membrane is pivotal for alleviating oxidative stress in OVX rats. Therefore, we investigated the distribution of subcellular ERα, ERβ and GPER protein levels and their level of colocalization with Cav3 in hearts collected from E 2 -depleted (OVX) rats following acute administration of E 2 or a highly selective ERα (PPT), ERβ (DPN) or GPER (G1) agonist. Further, we investigated the effect of PPT on the cellular distribution of ERβ and GPER relative to ERα in OVX rats to gain more insight into role of ERα-dependent cellular trafficking in the acute E 2 -mediated improvement of myocardial antioxidant/redox status in OVX rats [31] .
Material and methods

Animals
Female Sprague-Dawley rats (200-225 g, 12-13 weeks old, Charles River, Raleigh, NC) were housed two per cage in standard plastic cages, allowed free access to water and food (Prolab Rodent Chow; Granville Milling, Creedmoor, NC) and were maintained on a 12-12-h light-dark cycle with lights off at 7:00 p.m. Room temperature was maintained at 23 ± 1°C, with humidity of 50 ± 10%. All experiments were carried out in accordance with, and approved by the East Carolina University Institutional Animal Care and Use Committee (AUP# W237) and in accordance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory and Animal Resources, 2011).
Surgical preparation and ovariectomy
All surgeries were performed under aseptic conditions following anesthesia with intraperitoneal ketamine (90 mg/kg) and xylazine (10 mg/kg) injection as detailed in our recent study [32] . Each rat received subcutaneous injections of the analgesic buprenorphine hydrochloride (Buprenex, 30 μg/kg) and penicillin G benzathine and penicillin G procaine (Dura-Pen, 100,000 U/kg). Two weeks prior to intravascular cannulation for permit intravenous administration in Fig. 1 . Acute E 2 (1 μg/kg i.v., OVXE2) enhances ERα, but reduces ERβ and GPER, localization at the cardiac myocyte plasma membrane of ovariectomized (OVX) rats to comparable levels of sham-operated (SO) rats. A, C and E show representative confocal images of rat heart sections with ERα, ERβ or GPER-FITC (green) and Cav3-Cy3 (red) antibodies. Merged images highlight ERs and Cav3 colocalization (yellow). The bar graphs summarized the ratio of membrane ERα, ERβ or GPER vs Cav3, respectively (B, D and F).
Values are mean ± SEM of 4-5 hearts. *P b 0.05 vs SO, #P b 0.05 vs OVX.
conscious rats, bilateral ovaries were isolated and removed. Sham-operation (SO) was performed by exposing the ovaries without isolation.
Protocols and experimental groups
The hearts used in the present study were collected from rats used in our previous studies [31, 32] . Two weeks after ovariectomy, 5 groups of conscious OVX rats (n = 4-6) received a single injection of E 2 (1 μg/kg, i.v.), a selective ERα (PPT), ERβ (DPN) or GPER (G1) agonist (10 μg/kg, i.v., each) or vehicle (saline). The hearts of the sixth group of SO rats, collected during the proestrus phase (highest endogenous plasma E 2 levels) evaluated by vaginal smear [33] served as controls. Plasma estradiol levels were evaluated in SO, OVX and OVXE2 rats. The doses of E 2 and the selective agonists were based on reported studies [34, 35] , and the hearts were collected 90 min after drug or saline injection following euthanasia by over dose of phenobarbital, flash frozen in 2-methylbutane on dry ice, and stored at − 80°C. ER subtype subcellular localization and biochemical studies (ROS and catalase activity) were conducted on these tissues as described below.
Quantitative colocalization microscopy
Spatial distribution of ERs, in relation to Cav3 was investigated by dual labeling immunofluorescence in heart sections as previously described [36] . Briefly, hearts were equilibrated to −20°C and sectioned with a cryostat (HM 505E; Microm International GmbH, Waldorf, Germany). The heart tissue cryostat sections (20 μm thick) were postfixed in 4% paraformaldehyde on Polysine® coated microscope slides (Thermo Scientific LLC, Portsmouth, NH) and blocked for 2 h with 10% normal donkey serum (Jackson Immunoresearch Laboratories, West Grove, PA) in Tris-buffered saline containing 0.2% Tween-20 (TBST). After overnight incubation with the primary antibody (1:50 dilution v/ v), the sections were washed 3× with TBS, then incubated with the secondary antibody (1:150 dilution v/v) for 2 h and washed 1× with TBS containing 0.1% Triton-X. Coverslips were applied with Vectashield mounting medium with DAPI (Vector Laboratories, Inc., Burlingame, CA). Various combinations of the following primary antibodies were used for comparisons of subcellular localizations; mouse anti-ERα (Abcam, Cambridge, MA; ab2746), rabbit anti-ERα (Abcam; ab32063), mouse anti-ERβ (Abcam; ab16813), rabbit anti-ERβ (Abcam; ab3576), rabbit anti-GPR30 (Abcam; ab39742), mouse anti-Cav3 (BD Transduction Labs., San Jose, CA; 610421) and rabbit anti-Cav3 (Abcam; ab2912). The myocyte specific mouse anti-α-Actinin (Sarcomeric) antibody (Sigma Aldrich, St. Louis, MO, A7811) was used to verify that the sections analyzed were cardiomyocytes. The secondary antibodies used were: Cyanine3 (Cy3)-conjugated donkey anti-rabbit IgG (H + L) (Jackson ImmunoResearch; 711-165-152) and Fluorescein (FITC)-conjugated donkey anti-mouse IgG (H + L) (Jackson ImmunoResearch; 715-095-150). Control sections were incubated with only secondary antibodies to determine non-specific staining. A random sample of images across the heart section were acquired by laser scanning at wavelengths 488 and 543 nm using the Zeiss LSM 700 confocal microscope and the image analysis software ZEN 2012 (Carl Zeiss, Jena, Germany) keeping parameters constant throughout the acquisition process.
Colocalization image analysis
For colocalization quantification, we determined the fraction of ER that colocalized with Cav3 using the JACoP plug in for NIH ImageJ (http://rsbweb.nih.gov/ij/) as previously described [37] . Briefly, the degree of colocalization between the fluorophores ER-FITC (green) with Cav3-Cy3 (red) in the confocal images was quantified after background subtraction using Pearson's correlation coefficient (P r ), which performs intensity correlation coefficient-based (ICCB) analyses [38] . Further, the colocalization threshold tool was used to visualize the corresponding scatter plots of colocalization in NIH ImageJ. The values range from 1 to − 1 indicating full positive and negative correlation, respectively, while zero indicates no correlation [38] . For all measurements, we collected four to six images from four to six separate experiments.
ER plasma membrane ratios
The ERα/ERβ and ERα/GPER plasma membrane ratios were quantified using the following equations: Pr ERα; Cav3 Pr ERβ; Cav3 Pr ERα; Cav3 Pr GPER; Cav3 where P r ERα, Cav3 is Pearson's correlation coefficient of ERα with Cav3, and P r ERβ, Cav3 and P r GPER, Cav3 are Pearson's correlation coefficients of ERβ and GPER with Cav3, respectively.
Western blot analysis
Subcellular heart protein lysates of membrane, cytoplasmic and nuclear extracts were prepared using the Subcellular Protein Fractionation kit for tissues (Thermo Scientific, Pierce Biotechnology, Rockford, IL). Equal amounts of proteins (30 μg) were resolved by 10% SDS-PAGE and semi-dry transferred to nitrocellulose membranes (BIO-Rad), which undergone blocking for 2 h with Odyssey Blocking Buffer (LI-COR Biosciences, Lincoln, NE), then probed overnight at 4°C with a 
ROS measurement
Fresh unfixed heart sections (20 μm) were incubated with 10 μM dihydroethidium (DHE, Molecular Probes, Grand Island, NY) at 37°C in the presence of 5% CO 2 in a moist chamber for 30 min. Negative controls were used to determine non-specific staining. Images were visualized with a Zeiss LSM700 microscope. Four to six images were acquired from four to six heart sections for each experimental condition. After background subtraction, quantification of the fluorescent ethidium signal was conducted using ImageJ software (NIH) and changes in total fluorescence intensity were calculated as reported [39] .
Catalase activity assay
The commercially available colorimetric catalase assay kit from Sigma-Aldrich (St. Louis, MO) was used to measure catalase activity in 10 μg protein of ventricular homogenates according to the manufacturer's instructions and our recent study [31] .
Superoxide dismutase (SOD) activity assay
Myocardial SOD activity was measure by EnzyChrom Super Dismutase Assay Kit (EROD-100, BioAssay Systems, Hayward, CA) following the manufacturer's instructions.
Malondialdehyde (MDA) levels
TBARS Assay Kit (Cayman Chemical, Ann Arbor, MI, USA) was used to measure myocardial MDA level following the manufacturer's protocol and the method descripted in our publication [40] . The MDA-TBA adduct was detected colorimetrically at 530-540 nm. Fig. 4 . ERα protein level in membrane fraction extracts (ME) was increased, while reduced in cytoplasmic fraction extracts (CE) by acute E 2 (OVXE 2 , 1 μg/kg) treatment in OVX rat myocardial tissues. Levels of ERα protein in nuclear extracts (NE) were not changed. The amount of ERα protein level in ME, CE and NE represents mean band intensity normalized to NA/K ATPase, beta actin and Laminin B, respectively, and expressed as % of OVX (saline) values. Values are mean ± SEM of 4 hearts. *P b 0.05 vs OVX-ME, #P b 0.05 vs OVX-CE. 2.12. Determination of plasma 17β-estradiol 2.13. Plasma E 2 levels
Blood samples were collected from the artery catheter before hemodynamic experiment, centrifuged at 4000 rpm, 4°C for 10 min. The plasma was separated and stored at − 20°C. The estradiol level in the samples
Drugs
Ketamine and xylazine were purchased from Phoenix Pharmaceuticals Inc., (St Joseph, MI). Buprenorphine was purchased from Rickitt & Colman (Richmond, VA). Dura-Pen was from Vedco Inc. (Overland Park, KS). 17β-estradiol sulfate, Propylpyrazole triol (PPT) and 2,3-bis(4-hydroxyphenyl)-proprionitrile (DPN) were purchased from Sigma Aldrich (St. Louis, MO). G1 was purchased from Tocris Biosciences (Ellisville, MO). The ER agonists were dissolved in DMSO for stock solution and the working concentration was a 1:50 dilution in sterile saline. Sterile saline was purchased from B. Braun Medical (Irvine, CA).
Statistical analysis
DHE fluorescence intensity, catalase activity, receptor subtype plasma membrane ratios, and fluorescence colocalization (P r ) values were grouped, analyzed for normal distribution using one-way ANOVA with post hoc comparisons (HOLM-Sidak test) and presented as mean ± SEM. Correlation coefficients were obtained for ER plasma membrane ratios versus catalase activity using Pearson Product-Moment correlation measurements [42] . Western blot data was expressed as fold change versus OVX (saline) values and analyzed by unpaired t-test or ANOVA. Probability values (P) of b 0.05 were considered to be significant. All statistical analyses were conducted using Origin 8.5 (OriginLab, Northampton, MA) or Sigmastat 3.1 (Systat, San Jose, CA) software.
Results
Acute E 2 enhances ERα, reduces ERβ and GPER, localization at the cardiac myocyte membrane in OVX rats
Compared with SO rats, ovaryectomy significantly reduced the plasma E 2 level and acute E 2 (1 μg/kg) administration restored the E 2 level in OVX rats (Supplemental Fig. 1 ). The relative colocalization of ERα, ERβ or GPER with Cav3 at the cardiac myocyte membrane revealed significant (P b 0.05) reduction in ERα, and elevations in ERβ and GPER, localization at the plasma membrane in OVX, compared with SO rats. Acute E 2 (1 μg/kg) administration restored these patterns to those observed in SO rats (Fig. 1) . Therefore, E 2 depletion reduced (P b 0.05) the ERα/ERβ ( Fig. 2A) and ERα/GPER (Fig. 2B ) ratios at cell membrane, a phenomenon that was reversed by acute E 2 administration (Fig. 2) . Staining with the myocyte specific antibody, anti-α-actinin (Sarcomeric) antibody, confirmed that these responses occurred in cardiomyocytes (Supplemental Fig. 2A ). The inclusion of negative controls validated the specificity of the antibodies used in our study (Supplemental Fig. 2B ). E 2 also caused ERα translocation to plasma membrane (Supplemental Fig. 2C ) and ERβ to the nuclei (DAPI stained, Supplemental Fig. 2D ).
3.2. Selective activation of ERα, ERβ or GPER replicates the effect of E 2 on ER subtype localization at the cardiac myocyte plasma membrane in OVX rats Based on the relative localization of ERα, ERβ or GPER with Cav3 in the myocytes plasma membrane (Fig. 3A, B and C) , OVX rats exhibited higher (P b 0.05) ratios of ERβ/Cav3 and GPER/Cav3 than ERα/Cav3 (Fig. 3D) . Acute administration of a selective agonist (10 μg/kg) for ERα (PPT) enhanced (P b 0.05), while ERβ (DPN) or GPER (G1) reduced (P b 0.05), the localization of the targeted ER subtype at the plasma membrane (Fig. 3) .
To corroborate the immunofluorescence findings (Figs. 1-3) , we conducted Western blot analyses on myocardial membrane, cytoplasmic and nuclear fractions. Acute E 2 (1 μg/kg) significantly (P b 0.05) enhanced and reduced ERα protein level in the plasma membrane and cytoplasmic fractions, respectively, but had no effect on the ERα protein level in the nuclear fraction (Fig. 4) .
ERα plays a pivotal role in the E 2 mediated amelioration of oxidative stress
Compared with proestrus SO levels, OVX rats exhibited significantly (P b 0.05) higher myocardial ROS (Fig. 5) and MDA (Fig. 6D ) level (P b 0.05). These responses were reversed (P b 0.05) by acute E 2 (1 μg/kg) or PPT (10 μg/kg), but not by DPN or GPER (Figs. 5 and 6 ). Pearson Product-Moment Correlation analysis of data generated in OVX with and without E 2 showed inverse relationships ( Fig. 5C and D) between cardiac ROS levels and plasma membrane ratios of ERα/ERβ (r = −0.817; P b 0.05) or ERα/GPER (r = −0.762; P b 0.05).
ERα mediates E 2 -evoked enhancements of myocardial catalase and SOD activities, as well as Akt phosphorylation in OVX rats
OVX rats exhibited reduced (P b 0.05) myocardial catalase (Fig. 6A) and SOD (Fig. 6C ) activities, compared with SO rats. E 2 or PPT, but not DPN or G1, restored the activities of both enzymes to SO levels although E 2 was more effective in this regards (Fig. 6A, C) . Pearson Product-Moment Correlation analysis of data generated in OVX with and without E 2 showed positive relationships between catalase activity and the plasma membrane ratios of ERα/ERβ (r = 0.922; P b 0.05) or ERα/GPER (r = 0.822; P b 0.05) (Figs. 6B and C) . Finally, PPT or DPN increased (P b 0.05), while G1 had no effect on, the phosphorylation of the survival molecule Akt in the myocardium of OVX rats (Fig. 7) .
Discussion
The current study contributes the following new knowledge on E 2 modulation of subcellular distribution and function of the three ER subtypes in cardiomyocytes. Compared to proestrus SO rats, a drastic reduction in ERα/ERβ or ERα/GPER ratio at the cardiac myocyte membrane in OVX rats, was associated with myocardial oxidative stress and reduced catalase activity. Acutely administered E 2 restored ERα/ ERβ and ERα/GPER ratios to the levels in proestrus rats by concomitantly enhancing ERα, and reducing ERβ and GPER, localization at the myocyte membrane in OVX rats. Only PPT replicated these E 2 -mediated effects in OVX rats suggesting a pivotal role for ERα in the preferential regulation of ER subtype translocation to, and from, its subcellular locales. This E 2 -or PPT-dependent restoration of the ERα aggregation at the cell membrane is physiologically implicated in the E 2 antioxidant effect. This premise is supported by an ERα-dependent restoration of catalase and SOD activities and reduction of oxidative stress (ROS and MDA levels) in the myocardium of OVX rats.
Our finding on the relative cellular distribution of the individual ER subtype in the cardiac myocytes of proestrus SO and OVX rats support a preferential E 2 -driven ERα aggregation at the myocyte plasma membrane (Figs. 1-3) . This premise was supported by variations in ERα protein distribution (Western blot) in subcellular compartments in E 2 depleted (OVX) and replete (OVXE 2 ) rats. We show in OVX rats that acute E 2 administration increased and reduced ERα level in the plasma membrane, and cytoplasmic fraction, respectively, but had no effect on ERα protein level in nuclear extract (Fig. 4) or nucleus (Supplemental  Fig. 2C ). Interestingly, E 2 reduced ERβ level at plasma membrane (Fig.  1C, D) , at least partly, by enhancing its translocation to the nucleus (Supplemental Fig. 2D ). The translocation of a specific ER subtype might be tissue specific or time dependent. First, similar to our findings, short-term (minutes) exposure to 17β-estradiol increased the localization of ERα at plasma membrane of female rat anterior pituitary cell culture [43] , while a longer time (2 h) was needed for ERα translocation to the nucleus in cancer cells [44] . Second, E 2 induces rapid ERβ translocation to the membrane of rat primary-cultured cortical neurons [45] . More studies are needed to determine the time-dependence of ERα distribution within the different cellular components of the cardiac myocyte.
We adopted colocalization analysis using confocal images, which permitted visualization (Fig. 1A , C and E) and quantification (Fig. 1B , D and F) of ER subtype association with the plasma protein Cav3. It is important to comment on the impact of E 2 depletion (OVX) on the spatial distribution of the three ER subtypes in the cardiac myocyte relative to such distribution in E 2 replete conditions, particularly during the proestrus phase, which exhibits the highest endogenous E 2 level [33] . We found that the heart of OVX rat exhibited reduced ERα (Fig. 1B) , and enhanced ERβ (Fig. 1D) and GPER (Fig. 1F) , localization at the plasma membrane of cardiac myocyte. Therefore, in the presence of endogenous E 2 , ERα localization to the cardiac myocyte membrane (Fig. 1B) occurs at the expense of ERβ (Fig. 1D) and GPER (Fig. 1F) . Interestingly, homo-or heterodimer formation of the two ER subtypes, ERα and ERβ, can form at the membrane as the main component of a signaling complex, and is required for rapid signaling [10, 46] . In the case of nuclear E 2 action, ERβ often has the opposite effect of ERα [47, 48] . The membrane GPER interactions with the ER subtypes can also influence E 2 -mediated responses [28, 49] . It is likely that these 'Yin-Yang' relationships between the ER subtypes are influenced by the proportion of the ER subtypes available at the plasma membrane. Overall, the biological relevance of these endogenous E 2 driven plasma membrane ratios of the ER subtypes has not been seriously considered in reported studies.
We have shown that the reduction in myocardial catalase activity in OVX rats is restored to proestrus rat levels within minutes after E 2 administration [31] or selective ERα activation [32] . Further, we showed that acute ERα blockade by its selective antagonist MPP significantly reduced myocardial catalase activity in proestrus rats [40] . Collectively, these pharmacological findings support ERα mediation of cardiac catalase activation by acute or circulating E 2 . The current findings (Fig. 6A ) support this premise. Next, consistent with the premise that the spatial distribution of a protein plays a critical role in its function [50] , we present the first evidence that the aggregation of the ERα at the cell membrane is critical for its mediation of: (i) the enhancement of catalase activity ( Fig. 6B and C) , and (ii) the suppression of ROS (Fig. 5) and MDA (Fig. 6D ) levels in the OVX rat myocardium. ROS measurement was validated by two different assays in accordance with recent guidelines for ROS measurements [51] . However, it was important to determine if that the activation of ERα alone is enough to trigger the spatial distribution of the ERs in analogous manner to that caused by the endogenous hormone, E 2 .
We show, for the first time, that acute administration of the selective ERα agonist PPT produced similar biochemical response (Figs. 5 and 6) and ER subtype distribution pattern (Fig. 2) to those produced by E 2 in OVX rats. Equally compelling are the findings that the selective ERβ or GPER activation produced opposite effect to those produced by E 2 or by PPT because DPN or G1 suppressed myocardial catalase activity (Fig. 6A ) and did not reverse oxidative stress in OVX rats (Fig. 5) . These novel findings set forth the postulate that activation of ERs by E 2 triggers concomitant dissociation of ERβ and GPER from the myocyte plasma membrane consequent to the enhanced translocation of ERα to the plasma membrane. These ER trafficking events seem to contribute to the E 2 -dependent homeostasis within the rat myocardium because the predominance of ERα at the cardiac myocyte plasma membrane and its activation explain, at least partly, the acute antioxidant effect of E 2 (reduced ROS and MDA while enhancing myocardial catalase and SOD activities) in our model system. These current findings are important because enhancement of cardiac catalase activity alleviates myocardial oxidative in E 2 treated OVX rats [52] , and changes in cellular ER subtype ratios are linked to oxidative stress and antioxidant enzyme activity [53, 54] . Further, similar E 2 beneficial effects on the redox status were reported in female aortas and cardiac tissues [55, 56] , and catalase supplementation is linked to improvements in functional recovery of globally ischemic and perfused isolated hearts [57] . It is imperative to consider the contribution of other antioxidant enzymes to the ERα-dependent improvement of the myocardial redox status such as mitochondrial aldehyde dehydrogenase (mitALDH2) because it contributes to the antioxidant effect of E 2 [58] . Nonetheless, the present findings support a role for ERα signaling mechanisms in the cardiovascular protective effect of acute E 2 .
It is important to comment on the inability of selective ERα activation (PPT) to produce higher increases in catalase and SOD activities than that produced by E 2 in OVX rats. This was expected because the activities of both enzymes were suppressed following ERβ or GPER activation in OVX rats (Fig. 6A, C) . These findings are consistent with a downregulatory crosstalk where activated ERs can balance the net E 2 -mediated response through opposing influences. In support of this notion, PPT replicated E 2 -evoked dissociation of ERβ or GPER from plasma membrane ( Fig. 1D and F) . We must also consider the possibility that a crossover activation of the other ER subtype(s) by the selective agonists used in our study may have confounded data interpretation. This possibility is unlikely because, at the selected dose level, the agonists used in the present study are highly selective to their respective ER subtype; for example, PPT exhibits 400 fold preference to ERα and DPN exhibits 70 fold preference to ERβ and G1 is highly selective for GPER [25] [26] [27] . Therefore, the substantial selectivity of the utilized ER agonist, particularly the ERα agonist PPT, and the unique trafficking and biological activity of the ERα lend credence to our pharmacological approach and the novel data generated in our model system.
Conclusions
The current study provides important mechanistic information on the role of ER subtype trafficking in regulating the redox status of the rat myocardium. Specifically, the acute E 2 -mediated reversal of myocardial oxidative stress in E 2 depleted (OVX) rats is dependent on preferential ERα association with the myocyte cell membrane. Consistent with findings in other model systems [29, 48] , our data support the involvement of a crosstalk among the ER subtypes. While both PPT and DPN enhanced the phosphorylation of the survival molecule Akt (Fig. 7) , our novel findings support the hypothesis that ERα exhibits an additional function of triggering its translocation to the plasma membrane of cardiac myocyte. The latter seems to limit oxidative stress, at least partly, via enhancement of myocardial catalase and SOD activities. Finally, the findings highlight ERα agonists as potential therapeutics for restoring the myocardial redox status in postmenopausal women. 
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